AI assistant
HIKMA Pharmaceuticals PLC — Director's Dealing 2016
Dec 5, 2016
4841_dirs_2016-12-05_9de9ac8d-4528-400c-9fae-abff07f9eab6.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9861Q
Hikma Pharmaceuticals Plc
05 December 2016
Notification and public disclosure of transactions by persons discharging managerial responsibilities
The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the purchase by HMS Holdings SAL of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Chairman and Chief Executive, and the Vice Chairman shareholders in HMS Holdings SAL. This announcement is made in accordance with article 19.3 of MAR.
Said Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Said Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Chairman and Chief Executive Officer / PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Acquisition by HMS Holdings SAL of 350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Chairman and Chief Executive is a shareholder in HMS Holdings SAL with an equity interest of 29.16%. |
| c) | Price(s) and volume(s) | Price(s): £16.74 Volume(s): 350,000 |
| d) | Aggregated information | Aggregated volume: 350,000 Price: £16.74 |
| e) | Date of the transaction | 2 December 2016 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Mazen Darwazah
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Mazen Darwazah |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Vice Chairman / PDMR |
| b) | Initial notification /Amendment | Initial notification |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Hikma Pharmaceuticals PLC |
| b) | LEI | 549300BNS685UXH4JI75 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
| b) | Nature of the transaction | Acquisition by HMS Holdings SAL of 350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Vice Chairman is a shareholder in HMS Holdings SAL with an equity interest of 29.16%. |
| c) | Price(s) and volume(s) | Price(s): £16.74 Volume(s): 350,000 |
| d) | Aggregated information | Aggregated volume: 350,000 Price: £16.74 |
| e) | Date of the transaction | 2 December 2016 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Peter Speirs, Company Secretary, Responsible for releasing this announcement
5 December 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBDBDDDXGBGLU